These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Advances in the development of a vaccine against dengue]. Guzmán MG Acta Cient Venez; 1998; 49 Suppl 1():38-45. PubMed ID: 10030053 [TBL] [Abstract][Full Text] [Related]
23. A re-evaluation of the mechanisms leading to dengue hemorrhagic fever. Noisakran S; Chokephaibulkit K; Songprakhon P; Onlamoon N; Hsiao HM; Villinger F; Ansari A; Perng GC Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E24-35. PubMed ID: 19751399 [TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Bielefeldt-Ohmann H Trends Microbiol; 1997 Oct; 5(10):409-13. PubMed ID: 9351178 [TBL] [Abstract][Full Text] [Related]
29. Challenges for the formulation of a universal vaccine against dengue. Chokephaibulkit K; Perng GC Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907 [TBL] [Abstract][Full Text] [Related]
30. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Guzman MG; Alvarez M; Halstead SB Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635 [TBL] [Abstract][Full Text] [Related]
31. Towards a dengue vaccine: progress to date and remaining challenges. Guy B; Almond JW Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):239-52. PubMed ID: 17889365 [TBL] [Abstract][Full Text] [Related]
32. Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector. Raja NU; Holman DH; Wang D; Raviprakash K; Juompan LY; Deitz SB; Luo M; Zhang J; Porter KR; Dong JY Am J Trop Med Hyg; 2007 Apr; 76(4):743-51. PubMed ID: 17426182 [TBL] [Abstract][Full Text] [Related]
33. T lymphocyte responses to heterologous secondary dengue virus infections. Rothman AL Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400 [TBL] [Abstract][Full Text] [Related]
34. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
35. [Development in the analysis of the pathogenesis of dengue hemorrhagic fever, and current status of dengue vaccine]. Kurane I Uirusu; 2002 Jun; 52(1):15-20. PubMed ID: 12227165 [No Abstract] [Full Text] [Related]
36. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques. Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694 [TBL] [Abstract][Full Text] [Related]